loader
Please Wait
Applying Filters...
menu
    • menu

    Technical details about Vamorolone, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Vamorolone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 13209-41-1, Vamorolone [usan], Vbp-15 free alcohol, 17,21-dihydroxy-16alpha-methylpregna-1,4,9(11)-triene-3,20-dione, 16alpha-methyl-9,11-dehydro prednisolone, 8xp29xmb43
    Molecular Formula
    C22H28O4
    Molecular Weight
    356.5  g/mol
    InChI Key
    ZYTXTXAMMDTYDQ-DGEXFFLYSA-N
    FDA UNII
    8XP29XMB43
    Vamorolone is under investigation in clinical trial NCT03439670 (A Study to Assess the Efficacy and Safety of Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)).
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (8S,10S,13S,14S,16R,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-3-one
    2.1.2 InChI
    InChI=1S/C22H28O4/c1-13-10-18-16-5-4-14-11-15(24)6-8-20(14,2)17(16)7-9-21(18,3)22(13,26)19(25)12-23/h6-8,11,13,16,18,23,26H,4-5,9-10,12H2,1-3H3/t13-,16-,18+,20+,21+,22+/m1/s1
    2.1.3 InChI Key
    ZYTXTXAMMDTYDQ-DGEXFFLYSA-N
    2.1.4 Canonical SMILES
    CC1CC2C3CCC4=CC(=O)C=CC4(C3=CCC2(C1(C(=O)CO)O)C)C
    2.1.5 Isomeric SMILES
    C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4(C3=CC[C@@]2([C@]1(C(=O)CO)O)C)C
    2.2 Other Identifiers
    2.2.1 UNII
    8XP29XMB43
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Vbp15 Compound

    2.3.2 Depositor-Supplied Synonyms

    1. 13209-41-1

    2. Vamorolone [usan]

    3. Vbp-15 Free Alcohol

    4. 17,21-dihydroxy-16alpha-methylpregna-1,4,9(11)-triene-3,20-dione

    5. 16alpha-methyl-9,11-dehydro Prednisolone

    6. 8xp29xmb43

    7. (8s,10s,13s,14s,16r,17r)-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,12,14,15,16-hexahydro-6h-cyclopenta[a]phenanthren-3-one

    8. Chembl2348780

    9. Vbp15

    10. (8s,10s,13s,14s,16r,17r)-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,10,12,13,14,15,16,17-decahydro-3h-cyclopenta[a]phenanthren-3-one

    11. Unii-8xp29xmb43

    12. Vbp 15

    13. Einecs 236-177-8

    14. 16

    15. A-methyl-9,11-dehydro Prednisolone

    16. Vamorolone [inn]

    17. Vamorolone (usan/inn)

    18. Vamorolone [who-dd]

    19. Vbp15vbp15

    20. Schembl143459

    21. Gtpl9247

    22. Amy7535

    23. Dtxsid60927527

    24. Bdbm50432396

    25. Zinc33650317

    26. Db15114

    27. Pregna-1,4,9(11)-triene-3,20-dione, 17,21-dihydroxy-16-methyl-, (16.alpha.)-

    28. Hy-109017

    29. Cs-0030515

    30. Dexamethasone Impurity E [ep Impurity]

    31. D11000

    32. 16.alpha.-methyl-9,11-dehydroprednisolone

    33. J-006120

    34. Q27089127

    35. 17,21-dihydroxy-16.alpha.-methylpregna-1,4,9(11)-triene- 3,20-dione

    36. 17.alpha.,21-dihydroxy-16.alpha.-methylpregna-1,4,9(11)-triene-3,20-dione

    37. Delta-1,4,9(11)-pregnatriene-17-alpha,21-dihydroxy-16-alpha-methyl-3,20-dione

    2.4 Create Date
    2005-08-08
    3 Chemical and Physical Properties
    Molecular Weight 356.5 g/mol
    Molecular Formula C22H28O4
    XLogP32.7
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count4
    Rotatable Bond Count2
    Exact Mass356.19875937 g/mol
    Monoisotopic Mass356.19875937 g/mol
    Topological Polar Surface Area74.6 Ų
    Heavy Atom Count26
    Formal Charge0
    Complexity775
    Isotope Atom Count0
    Defined Atom Stereocenter Count6
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Treatment of Duchenne muscular dystrophy